Next Generation Sequencing (NGS) technology allows the simultaneous analysis of multiple genes.
A pan-lymphoid NGS panel is available for DNA sequence variants. Virtual sub-panels will be applied to all suspected referrals of mantle cell lymphoma, hairy cell leukaemia, CLL, follicular lymphoma, lymphoplasmocytic lymphoma, Burkitt lymphoma, B-NHL, T-NHL and Histiocytosis with information on additional genes available on request.
Fusion gene testing by RNAseq is also available on request. This assay is designed to detect relevant fusions that act via generation of a chimeric RNA transcript.